Reporting on market developments concerning The Fast-Cash Advances Draining America's Small Businesses. Industry analysts and investors are monitoring the operational, strategic, a...

Alternative lenders promise instant liquidity to Main Street enterprises, but aggressive repayment terms and triple-digit effective rates are fueling a quiet wave of insolvencies.

Intel stock fell sharply after the semiconductor pioneer reported compressed profit margins and delivered revenue forecasts that trailed Wall Street expectations.

Chevron is renewing its search for oil and natural gas in frontier international basins, balancing domestic shale with high-impact deepwater prospects.

Merck posted robust top-line gains driven by enduring demand for blockbuster oncology drug Keytruda and rapid market adoption of newly launched Winrevair.

Intensifying shareholder activism and tightening capital markets are placing corporate chief executives on an unprecedented collision course with investors.

Institutional asset managers are moving past vague ESG pledges, demanding audited data, verifiable KPIs, and standardized frameworks to measure true social return.

The Federal Reserve opted to keep benchmark interest rates unchanged, though dissents from two policymakers underscore internal debate over stubborn inflation.

Mega-cap technology equities maintained upward momentum while government bonds faced selling pressure as Wall Street positioned for the Federal Reserve's rate decision.

Rising life expectancy and shifting pension dynamics are compelling professionals and wealth managers to restructure careers and long-term capital allocation strategies.

Despite premium seats topping $400, top global opera institutions face widening structural deficits driven by Baumol's cost disease and shifting patronage.

U.S. stock futures traded in a tight band as enthusiasm around artificial intelligence cooled and traders weighed emerging political developments across the Middle East.